Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2023-10-01
2024-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of a Single Dose of Bright Light Treatment on Measures of Affective Information Processing
NCT03688048
Light-Emitting Diode (LED) Light for Seasonal Affective Disorder (SAD) Treatment
NCT00114322
Neurobiological Effects of Light on MDD
NCT02940769
Efficacy of Blue Light Treatment in Patients With Nonseasonal Major Depressive Disorder
NCT04555408
Phototherapy in Young People With Depression
NCT02448433
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Scene
High fidelity scene of nature emitted from a monitor
Light exposure
Participants will be exposed to 15 minutes of each arm. They will be exposed twice and a randomized order (1/2/1/2 or 2/1/2/1)
Scrambled scene
The same pixels that are used to create the scene in the alternate arm will be randomly scrambled on the monitor
Light exposure
Participants will be exposed to 15 minutes of each arm. They will be exposed twice and a randomized order (1/2/1/2 or 2/1/2/1)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Light exposure
Participants will be exposed to 15 minutes of each arm. They will be exposed twice and a randomized order (1/2/1/2 or 2/1/2/1)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Mild depressive symptomatology
Exclusion Criteria
* Severe depressive symptomatology
* Active or unstable medical condition
* Diabetes
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
VA Palo Alto Health Care System
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jamie M. Zeitzer, Ph.D.
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VA Palo Alto Health Care System
Palo Alto, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB-71791
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.